10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,627,601 | -19.6% | 39,457 | +8.8% | 0.08% | -25.5% |
| Q2 2023 | $2,024,256 | -19.0% | 36,251 | -19.1% | 0.10% | -14.3% |
| Q1 2023 | $2,498,499 | +111.9% | 44,784 | +38.4% | 0.12% | +70.0% |
| Q4 2022 | $1,179,126 | +27.9% | 32,358 | 0.0% | 0.07% | +12.9% |
| Q3 2022 | $922,000 | -37.0% | 32,358 | 0.0% | 0.06% | -30.3% |
| Q2 2022 | $1,464,000 | -33.5% | 32,358 | +11.9% | 0.09% | -18.3% |
| Q1 2022 | $2,200,000 | -42.4% | 28,923 | +12.9% | 0.11% | -23.8% |
| Q4 2021 | $3,818,000 | +11.9% | 25,629 | +9.4% | 0.14% | -5.9% |
| Q3 2021 | $3,411,000 | -25.7% | 23,433 | 0.0% | 0.15% | -33.6% |
| Q2 2021 | $4,589,000 | +21.4% | 23,433 | +12.2% | 0.23% | +31.6% |
| Q1 2021 | $3,781,000 | +91.6% | 20,889 | +49.9% | 0.17% | +100.0% |
| Q4 2020 | $1,973,000 | +15.2% | 13,933 | +1.5% | 0.09% | -12.1% |
| Q3 2020 | $1,712,000 | +157.4% | 13,733 | +84.5% | 0.10% | +115.2% |
| Q2 2020 | $665,000 | – | 7,444 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |